MappBio Collaborates with Aridis Pharmaceuticals to Develop Therapies Utilizing APEX Technology

 MappBio Collaborates with Aridis Pharmaceuticals to Develop Therapies Utilizing APEX Technology

MappBio Collaborates with Aridis Pharmaceuticals to Develop Therapies Utilizing APEX Technology

Shots:

  • MappBio collaborates with Aridis Pharmaceuticals to develop mAbs productivity enhanced versions of CHO cell lines utilizing Aridis’s APEX Technology
  • CHO cell lines are developed from Chinese hamster ovary. The CHO cell line are developed by MappBio
  • APEX technology is a mAb discovery platform that enables the screening and single cell cloning of antibody producing B-cells using microarrays and is built upon Aridis’ hybridoma-based technology platform, MabIgX allowing rapid fusion and production of mAbs directly from patients antibody-producing B-cells

Click here to read full press release/ article | Ref: Aridis Pharmaceuticals | Image: Twitter

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post